November 01, 2025
The anti-aging market size is expected to rise from USD 84.4 billion in 2026 to USD 129.88 billion by 2034, gr...
Read MoreNovember 13, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreNovember 26, 2025
The U.S. behavioral health market is anticipated to grow from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreNovember 01, 2025
The simulators market size is projected to expand from USD 14.72 billion in 2026 to USD 25.53 billion by 2034,...
Read MoreOctober 17, 2025
The global Pre-Dx oncology market is growing with rising cancer incidence and advanced early detection technologies. North America led with 45% share in 2024, while Asia Pacific is fastest-growing. Liquid biopsy tests accounted for 40% revenue, MCED tests show high CAGR, and NGS made up 38% of technology revenue. Blood and urine are key sample type...
October 16, 2025
The oncology biomarker market is valued at USD 38.62 billion in 2025 and is projected to reach USD 113.54 billion by 2034, growing at a CAGR of 12.73%. The report covers market segments by biomarker type, including genomic (35% share in 2024) and proteomic biomarkers, application types such as diagnostic testing (50% share in 2024) and prognostic t...
October 08, 2025
Market insights predict, the pneumonia testing industry is expected to grow from USD 1.97 billion in 2024 to USD 3.85 billion by 2034, driven by a CAGR of 6.97%. The rising prevalence of pneumonia and the growing demand for early diagnosis drive the market. The availability of a robust healthcare infrastructure and favorable reimbursement policies ...
October 01, 2025
Projections indicate that, biochip industry is projected to rise from USD 12.75 billion in 2024 to USD 42.15 billion by 2034, reflecting a CAGR of 12.7% over the next decade. The biochip market is growing because biochips have many applications, such as medical diagnostics, drug development, personalized medicine, continuous health monitoring, neur...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com